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  Ehrlichia (E.) canis is a Gram-negative obligate intracellular 
bacterium  responsible  for  canine  monocytic  ehrlichiosis. 
Currently,  the  genetic  diversity  of  E.  canis s t r a i n s  
worldwide  is  poorly  defined.  In  the  present  study, 
sequence  analysis  of  the  nearly  full-length  16S  rDNA 
(1,620 bp) and the complete coding region (4,269 bp) of 
the  gp200  gene,  which  encodes  the  largest  major 
immunoreactive  protein  in  E.  canis,  from  17  Taiwanese 
samples  was  conducted.  The  resultant  16S  rDNA 
sequences  were  found  to  be  identical to each  other  and 
have  very  high  homology  (99.4∼100%)  with  previously 
reported  E.  canis  sequences.  Additionally,  phylogenetic 
analysis  of  gp200  demonstrated  that  the  E.  canis 
Taiwanese  genotype  was  genetically  distinct  from  other 
reported isolates obtained from the United States, Brazil, 
and  Israel,  and  that  it  formed  a  separate  clade. 
Remarkable variations unique to the Taiwanese genotype 
were found throughout the deduced amino acid sequence 
of  gp200,  including 15  substitutions occurring  in two of 
five known species-specific epitopes. The gp200 amino acid 
sequences  of  the  Taiwanese  genotype  bore  94.4∼94.6 
identities with those of the isolates from the United States 
and Brazil, and 93.7% homology with that of the Israeli 
isolate.  Taken  together,  these  results  suggest  that  the 
Taiwanese genotype represents a novel strain of E. canis 
that has not yet been characterized.
Keywords: canine ehrlichiosis, Ehrlichia canis, gp200 gene, 
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Introduction 
Ehrlichia (E.) canis, which is the primary etiologic agent 
of canine monocytic ehrlichiosis (CME), is a Gram- 
negative obligate intracellular bacterium that replicates in 
monocytes and macrophages [5]. E. canis is primarily 
transmitted by the brown dog tick Rhipicephalus 
sanguineus [2]. CME has been reported throughout the 
world, with a higher frequency in tropical and subtropical 
regions [12]. Dogs infected with E. canis can present with 
a wide spectrum of symptoms, ranging from subclinical 
infection to death [1,6,11]. Clinical signs often include 
anorexia, dyspnea, hyperthermia, lethargy, weight loss, 
and bleeding disorders [3,4,22]. 
Although the genome of the E. canis prototype strain Jake 
was completely sequenced in 2006 [8], the genetic 
diversity of E. canis strains worldwide is still poorly 
defined. To date, most molecular epidemiology studies of 
E. canis have focused on the 16S ribosomal RNA gene 
(16S rDNA), while much less is known about the other 
genes. Unfortunately, molecular characterization of the 
16S rDNA has provided little information regarding strain 
diversity and suggests a high level of conservation [16,20, 
21]. It has been reported that the 16S rDNA partial 
sequences were 99.9∼100% identical among isolates of 
E. canis from South America (VHE and VDE isolates), 
North America (Oklahoma isolate), Asia (Thai, Chinese, 
and Japanese Kagoshima isolates), and the Middle East 
(Turkish and Israeli isolates) [15,23]. These observations 
indicated that the 16S rDNA sequence might not be the 
best target for evaluation of the genetic diversity of E. 
canis. 
Zhang et al. [24] recently analyzed and compared the 
gp200 gene sequences of E. canis isolates from the United 
States, Brazil and Israel and found that gp200 was highly 
conserved between the isolates from the USA and Brazil, 
but that substantial diversity was present in the Israeli 
isolate. The gp200 gene encodes the largest major 
immunoreactive protein that has been identified in E. canis 
to date [10,14]. The gp200 protein has been shown to be 
especially sensitive to immunodiagnositic antigen for E. 
canis infections and to provide species specificity [9]. 
Investigation of the extent of sequence variation in this 
antigen candidate may help elucidate the diversity of E. 334    Chia-Chia Huang et al.
Table 1. Primers used for amplification and sequencing of the 16S rRNA and gp200 genes from Taiwanese samples of Ehrlichia canis
 Target  Primer  Sequence  Expected size
16S rDNA EC16-F1  5´- AGG CGG CGA TGC ATA ATA GCT -3´  940 bp
  EC16-R2  5´- GGA GTG CTT AAC GCG TTA GCT -3´
  EC16-F2  5´- GGT AGT CCA CGC TGT AAA CGA -3´  805 bp
  EC16-R1  5´- AGA CGG CGT AGC ACC TTA TCA -3´
gp200 EC200-F1  5´- TGT CAT TCT AAA GCT TGG TTT ATC CT -3´  1,389 bp
  EC200-R1  5´- GTG GCA AAT GTT CAA CAG CAT G -3´
  EC200-F2  5´- CAC AGA AGC CAG ATT GTT CTG T -3´  1,075 bp
EC200-R2  5´- GGA GTA GGA GTT GCT GAA GTC T -3´
EC200-F3  5´- GGG ATT CGT TAC ACC TAC CAA GT -3´  1,286 bp
EC200-R3  5´- GTC CGC AGC ACG ATA ATC AGA TA -3´
EC200-F4  5´- ACA TCC AAG ATA CGC AAA GGA GA -3´  1,292 bp
EC200-R4  5´- ACC TGC ACC TCA TAT CCA ACT -3´
canis isolates and pave the way for development of an 
effective vaccine for CME. Herein, we analyzed the 
sequence variations in the gp200 gene of the E. canis 
parasite from naturally infected dogs in Taiwan. To define 
the genotype of the organism, the 16S rDNA was also 
analyzed. 
Materials and Methods
Blood samples and microscopic examination
Eighty-seven blood samples were collected from dogs 
exhibiting clinical signs compatible with ehrlichiosis that 
presented to the Veterinary Teaching Hospital of National 
Chung Hsing University and eight veterinary clinics 
throughout Taiwan during 2009. Blood was collected into 
sterile tubes containing anticoagulant (EDTA) and then 
stored at 4
oC until arrival at the laboratory for further 
processing. Giemsa-stained blood smears were examined 
by light microscopy (by observing 100 microscopic fields 
at 1,000× magnification) for the presence of morulae or 
inclusion bodies of E. canis. Genomic DNA was extracted 
from 200 μL of whole blood samples using a QIAamp 
DNA Blood Mini Kit (Qiagen, USA) according to the 
manufacturer’s protocol. Nucleic acid was eluted into 100 
μL of elution buffer and stored at −20
oC until further use.
PCR amplification
The oligonucleotide primers used for the amplification of 
E. canis genes (16S rDNA and gp200) were designed using 
primer design software (PrimerSelect; DNAStar, USA) 
and information from the E. canis genome (GenBank 
accession number CP000107) [8]. All primers used in this 
study are shown in Table 1. For each PCR amplification, 5 
μL of extracted DNA was used as the template in a 25 μL 
reaction mixture containing 1× PCR buffer (Promega, 
USA), 2.5 mM MgCl2, 0.2 mM deoxynucleotide 
triphosphates (dNTPs), 0.8 μM of each primer and 0.125U 
TaqBead Hot Start Polymerase (Promega, USA). The 
reactions were conducted in an ABI2700 thermocycler 
(Applied Biosystems, USA) according to the following 
parameters: 94
oC for 3 min followed by 35 cycles of 94
oC 
for 1 min, 58
oC for 1 min and 72
oC for 1.5 min, followed by 
an extension step at 72
oC for 5 min.
Cloning and sequencing
The resulting PCR products were electrophoresed on a 
1.2% agarose gel that was stained with ethidium bromide 
to check the size of the amplified fragments by comparison 
to a DNA molecular weight marker (100-bp DNA Ladder; 
Promega, USA). In each case, the single amplified product 
of the expected size was column purified using the 
QIAquick PCR Purification Kit (Qiagen, USA) and then 
ligated into the pGEM-T vector (Promega, USA) for 
subsequent transformation in Escherichia coli DH5α 
competent cells. One plasmid vector containing the insert 
was purified from each clone using the QIAprep Spin 
Miniprep Kit (Qiagen, USA), after which it was sequenced 
using an ABI PRISM 3730 capillary sequencer (Applied 
Biosystems, USA) and the Dye Terminator Cycler 
Sequencing Kit (Applied Biosystems, USA) with the T7 or 
SP6 vector primer. Both the sense and antisense strands of 
each PCR-amplified product were sequenced, and the 
sequences were then manually edited to resolve 
ambiguities. A consensus sequence was obtained for each 
amplified PCR product by comparing both the sense and 
antisense sequences.
Sequence and phylogenetic analyses
The BLAST program (NCBI, USA) was used for 
comparison and analysis of sequence data obtained in this 
study versus those previously deposited in the GenBank 
database. Multiple sequence alignment was conducted gp200-based phylogenetic analysis of Ehrlichia canis     335
Fig. 1. Photomicrographs of the Giemsa-stained thin blood smear
showing (A) Ehrlichia  (E.) canis morula and (B) E. canis
inclusion bodies.
Fig. 2. Phylogenetic tree based on the partial 16S rDNA 
sequences of E. canis isolates. To root the tree, the corresponding
sequence of Neorickettsia (N.) sennetsu was used as an outgroup.
Accession numbers for E. canis isolates and the outgroup species
N. sennetsu are given in parentheses. The scale bar indicates the
number of substitutions per nucleotide position. The numbers at
the nodes represent the percentage of 1,000 bootstrap 
resamplings.
using Clustal W version 1.8 [18]. Phylogenetic trees were 
inferred using the neighbor-joining method as 
implemented by the MEGA software version 4 [17]. The 
distance matrix of amino acid divergences was calculated 
according to Kimura’s two-parameter model furnished by 
MEGA. A bootstrap resampling technique of 1,000 
replications was conducted to statistically support the 
reliabilities of the nodes on the trees. 
Results
The morulae or inclusion bodies of E. canis were detected 
by microscopic examination in 17 out of 87 blood smears 
(19.6%) of dogs exhibiting clinical signs compatible with 
ehrlichiosis (Fig. 1). Positive blood samples from these 
parasitemic dogs were subjected to DNA extraction, 
amplification and sequencing. All 16S rDNA sequences of 
1,620 bp derived from 17 samples were found to be 
identical to each other. The representative sequence 
obtained from this study has been deposited in the 
GenBank database under accession number GU810149. 
The sequence had 100% identity with the corresponding 
sequences from E. canis isolates in Brazil (GenBank 
accession numbers EF195134), Greece (EF011110-1), 
Italy (EU439944), Turkey (AY621071), Venezuela 
(AF373612-3), and Thailand (EU263991 and EF139458), 
99.9% homology with a Japanese isolate (AF536827) and 
a strain from the USA (M73221), 99.8% identity with a 
Chinese isolate (AF162860), 99.7% identity with a South 
American isolate (DQ915970), 99.7% homology with an 
Israeli isolate (U26740), and 99.4% identity with a Spanish 
isolate (AY394465). A phylogenetic tree of E. canis was 
inferred based on the 16S rDNA sequences obtained in this 
study and others (Fig. 2). Consistent with the results of 
previous studies [15,16,21], the E. canis 16S rDNA 
sequences generated in this study were very similar to 
those from other countries.
Nevertheless, there was substantial variation in the gp200 
gene sequences between the Taiwanese samples and other 
previously reported isolates. According to the gp200 
nucleotide sequences of the E. canis isolates from the 
United States (AF252298 and CP000107), the gp200 open 
reading frame was 4,266 bp in length and encoded a protein 
of 1,421 amino acids. The complete gp200 coding 
sequences derived from 17 Taiwanese samples were 
identical or nearly identical to each other (99.9∼100% 
identities), even though the canine blood samples were 
obtained from different locations. The three representative 
sequences obtained from this study have been deposited in 
the GenBank database under accession numbers 
GU810148 (n = 8), HM067841 (n = 4) and HM067842 (n 
= 5). The only two nucleotide differences among these 
sequences occurred at positions 3591 and 3624. However, 
these variations did not cause any changes in amino acids. 
Notably, all of these sequences had three nucleotide 
insertions at positions between 4077 and 4078, 4081 and 
4082, and 4082 and 4083 (based on the E. canis strain 
AF252298 numbering system) and thus consisted of 4,269 
bp.
Comparative sequence analysis of the 4,269-bp products 
generated for the E. canis Taiwanese samples (TWN; 
provisionally designated as the TWN genotype) revealed 
that it had 97.9∼98.0% homology with the corresponding 
sequences obtained from the USA Jake2 isolate (CP000107) 
and the Brazilian Sao Paulo isolate (EF636664), 97.8∼
97.9% homology with the sequence of the USA Jake1 isolate 
(AF252298), and 97.5∼97.6% homology with the 
sequence of the Israeli 611 isolate (EF636665).336    Chia-Chia Huang et al.
Fig. 3. Alignment of the deduced amino acid sequences of E. canis gp200. Amino acids highlighted in grey represent residues divergent
from the USA Jake1 isolate (US1) sequence, while dashes represent gaps. The underlined regions indicate known dominant 
species-specific antibody epitopes. The GenBank accession number for each sequence is given at the end of the sequence. 
Abbreviations of specific E. canis strains - US2: USA Jake2 isolate, BRZ: Brazilian Sao Paulo isolate, ISR: Israeli 611 isolate, TWN:
Taiwanese sample.gp200-based phylogenetic analysis of Ehrlichia canis     337
Fig. 3. Continued.
The deduced amino acid sequence of gp200 of the TWN 
genotype was aligned with the corresponding sequences of 
four other published isolates. When compared with the 
sequence of the USA Jake1 isolate, 79 amino acid changes 
scattered throughout the gp200 sequence of the TWN 
genotype were observed (Fig. 3). Of these changes, 15 
amino acid residues occurred in two of five known 
species-specific antibody epitopes [14]. Overall, the TWN 338    Chia-Chia Huang et al.
Fig. 4. Phylogenetic tree based on deduced amino acid sequences 
of the E. canis gp200. To root the tree, the sequence of an 
ortholog (ankyrin protein 200) in E. chaffeensis was used as an 
outgroup. Accession numbers for E. canis isolates and the 
outgroup species E. chaffeensis are given in parentheses. The 
lengths of the lines are proportional to the number of amino acid
changes. The scale bar at the lower left indicates the number of 
substitutions per sequence position. The numbers at the nodes 
represent the percentage of 1,000 bootstrap resamplings.
Fig. 5. The specificity and detection limit of the gp200-targeted
PCR amplification using the primer set EC200-F3/R3. (A) The 
DNA extracted from blood samples of dogs infected by different
rickettsia (Lane 1: E. canis, Lane 2: E. chaffeensis, Lane 3: E. 
ewingii, Lane 4: A. platys, Lane 5: B. canis vogeli, Lane 6: B. 
gibsoni) and a healthy dog (Lane 7) were subjected to PCR. The 
products were electrophoresed on a 1.2% agarose gel and stained
with ethidium bromide. Lane M, 100-bp DNA ladder marker; 
Lane 8: no template DNA. (B) The blood sample with 5% 
parasitemia was serially diluted 10-fold from 10
0 to 10
򰠏7 (Lanes 
1-8, respectively) with blood obtained from a healthy dog. Lane
M, 100-bp DNA ladder marker; Lane 9: no template DNA.
genotype had 94.4% homology with the amino acids of the 
USA Jake1 isolate, 94.6% homology with the USA Jake2 
isolate, 94.5% homology with the Brazilian Sao Paulo 
isolate, and 93.7% homology with the Israeli 611 isolate. 
A phylogenetic tree of E. canis was inferred based on the 
gp200 amino acid sequences obtained in this study and 
four other reported sequences [24]. In this tree, the gp200 
sequence from the TWN genotype differed distinctly from 
other corresponding sequences of E. canis isolates from 
North America (the United States), South America 
(Brazil), and West Asia (Israel), and formed a separate 
phylogenetic clade (Fig. 4). 
Finally, the specificity and detection limit of the four sets 
of PCR primers used for gp200 amplification (Fig. 5) were 
evaluated. For the purpose of specificity testing, the 
genomic DNA extracted from an E. canis-positive dog 
blood sample with 5% parasitemia was used to conduct 
PCR followed by agarose gel electrophoresis. The results 
showed that each of the four primer sets generated 
individual amplified products of the expected size, whereas 
no product was detected in reactions conducted without 
template DNA or using DNA that was separately extracted 
from blood samples of a healthy dog and dogs infected 
with different types of rickettsia, including Ehrlichia 
chaffeensis, Ehrlichia ewingii, Anaplasma platys, Babesia 
canis vogeli, and Babesia gibsoni. Among the four primer 
sets examined, EC200-F3/R3 exhibited the clearest pattern 
(Fig. 5A). Subsequently, the sensitivity of the PCR assay 
using this primer set was also determined. The blood 
sample with 5% parasitemia was serially diluted 10-fold 
with blood obtained from a healthy dog. The DNA 
extracted from these dilutions was used to determine the 
detection limit. As shown in Fig. 5B, the PCR results 
indicated that the lowest detection limit was 0.00005 
parasitemia.
Discussion
While canine E. canis infection is considered to be 
enzootic throughout Taiwan, this conclusion is based on 
clinical signs, hematological abnormalities and 
microscopic examination of Giemsa-stained blood smears 
or serological evaluations such as enzyme-linked 
immunosorbent assays. In the present study, the nearly 
full-length 16S rDNA of E. canis from 17 infected dogs 
was amplified and sequenced, providing molecular 
evidence that this etiologic agent is involved in canine 
disease in Taiwan. Although the generated 16S rDNA 
sequences showed a very low diversity when compared 
with those from other geographically distinct isolates, 
additional analysis of the antigen-encoding gene gp200 
helped identify genetic variations among E. canis isolates. 
E. canis gp200 is a secreted nuclear translocated ankyrin 
repeat-containing protein that has five major species- gp200-based phylogenetic analysis of Ehrlichia canis     339
specific epitopes that are primarily located in terminal 
acidic domains [14]. The protein has been shown to elicit 
strong antibody responses in the acute phase of the 
infection [24]. The development of a widely applicable 
vaccine for CME is undoubtedly dependent on an 
understanding of genetic differences that may exist in 
geographically dispersed strains of E. canis, particularly 
with respect to the genes coding for immunodominant 
antigens, such as gp200. Previous studies have reported 
that gp200 had a high level of conservation between the 
USA and Brazil isolates, but that substantial divergence 
was present in the Israeli isolate [14,24]. In the present 
study, we found that amino acid changes in gp200 from the 
TWN genotype were distributed throughout the protein, 
and that some of the amino acid substitutions occurred in 
known E. canis-specific epitopes [14]. Notably, most of 
the amino acid substitutions in epitope-containing regions 
were dimorphic, containing only two different amino acids 
at positions wherever substitutions occur. With respect to 
the Israeli isolate, it has been suggested that amino acid 
substitutions in gp200 epitopes are responsible for the 
lower immunoreactivity of the protein with heterologous 
antisera when compared with homologous Israeli antisera 
[24]. Accordingly, it would be interesting to determine if 
notable differences in the TWN genotype are involved in 
any antigenic variability. 
Conversely, the sequence divergence in the gp200 gene 
among geographically distributed E. canis strains examined 
in this study and others has provided useful information 
regarding a possible new target for genotyping of the 
organism. The results presented here also expand our 
knowledge of the genetic variability of E. canis and 
encourage further research for the analysis of genetic 
variation of E. canis strains worldwide using additional 
samples. Further studies of E. canis isolates with greater 
global distribution may enable inference of the 
phylogeographic patterns of these strains. Considering that 
the clinical outcome of E. canis infection vary widely from 
death to an asymptomatic chronic carrier state in untreated 
animals [4,6,13,19], it would be of interest to assess the 
relationship between genetic variations in gp200 and strain 
infectivity or virulence of E. canis. 
In summary, the present study documents infection of 
dogs with E. canis from Taiwan using molecular methods. 
Molecular evidence indicates that the E. canis genotypes 
circulating in dogs in Taiwan appear to be highly 
conserved. Based on phylogenetic analysis of the gp200 
sequences, it is clear that the Taiwanese genotype reported 
here represents a novel strain of E. canis that has not yet 
been characterized. Additionally, the divergence of gp200 
among geographically dispersed strains examined in this 
study and others supports the conclusion that this gene is 
useful for molecular genotyping of E. canis.
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